ModerateBenzodiazepines. Short-to-medium-acting anxiolytics×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Additive sedation. No direct pharmacokinetic interaction – escitalopram does not significantly block CYP3A4.
Symptoms
Additional drowsiness, ataxia in the first 1–2 weeks. Older patients: fall risk.
Management
Widely used in anxious-depressive disorders. Alprazolam is given for a short course (4–6 weeks) with gradual taper after escitalopram's effect stabilises. In older patients: minimum alprazolam dose; monitor cognition.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- FDA: Lexapro (escitalopram) prescribing information (2023)– FDA label, Allergan, Inc., DailyMed setid 13bb8267-1cab-43e5-acae-55a4d957630a, revised 10/2023, sections 4, 5.2 and 7